The metabolic syndrome, IGF-1, and insulin action

Molecular and Cellular Endocrinology

Volumn 299, Issue 1, 2009, Pages 124-128

  Arai, Yasumichi ^a   Kojima, Toshio ^b   Takayama, Michiyo ^a   Hirose, Nobuyoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

Adipokines; Aging; Centenarian; Insulin IGF 1 signaling; Longevity; Metabolic syndrome

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C;

ADIPOSE TISSUE; AGING; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; HOMEOSTASIS; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LONGEVITY; METABOLIC DISORDER; PRIORITY JOURNAL; TISSUE METABOLISM;

AGING; ANIMALS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION;

EID: 58349092062     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.07.002     Document Type: Article

References (64)

1. Arai Y., Hirose N., Yamamura K., Shimizu K.I., Takayama M., Ebihara Y., and Osono Y. Serum insulin-like growth factor-1 in centenarians: implications of IGF-1 as a rapid turnover protein. J. Gerontol. A: Biol. Sci. Med. Sci. 56 (2001) M79-M82
2. Arai Y., Nakazawa S., Kojima T., Takayama M., Ebihara Y., Shimizu K., Yamamura K., Homma S., Osono Y., Gondo Y., Masui Y., Inagaki H., Kitagawa K., and Hirose N. High adiponectin concentration and its role for longevity in female centenarians. Geriatr. Gerontol. Int. 6 (2006) 32-39
3. Arai, Y., Tayama, M., Gondo, Y., Inagaki, H., Yamamura, K., Nakazawa, S., Kojima, T., Ebihara, Y., Shimizu, K., Masui, Y., Kitagawa, K., Takebayashi, T., Hirose, N., in press. Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. J. Gerontol. A: Biol. Sci. Med. Sci.
4. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
5. Bartke A. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 146 (2005) 3718-3723
6. Barzilai N., Atzmon G., Schechter C., Schaefer E.J., Cupples A.L., Lipton R., Cheng S., and Shuldiner A.R. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 290 (2003) 2030-2040
7. Besson A., Salemi S., Gallati S., Jenal A., Horn R., Mullis P.S., and Mullis P.E. Reduced longevity in untreated patients with isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 88 (2003) 3664-3667
8. Bik W., Baranowska-Bik A., Wolinska-Witort E., Martynska L., Chmielowska M., Szybinska A., Broczek K., and Baranowska B. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro. Endocrinol. Lett. 27 (2006) 493-500
9. Bluher M., Kahn B.B., and Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299 (2003) 572-574
10. Bonafe M., Barbieri M., Marchegiani F., Olivieri F., Ragno E., Giampieri C., Mugianesi E., Centurelli M., Franceschi C., and Paolisso G. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J. Clin. Endocrinol. Metab. 88 (2003) 3299-3304
11. Bonkowski M.S., Rocha J.S., Masternak M.M., Al-Regaiey K.A., and Bartke A. From the cover: targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7901-7905
12. Brown-Borg H.M., Bode A.M., and Bartke A. Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process. Endocrine 11 (1999) 41-48
13. Cappola A.R., Xue Q.L., Ferrucci L., Guralnik J.M., Volpato S., and Fried L.P. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J. Clin. Endocrinol. Metab. 88 (2003) 2019-2025
14. Clancy D.J., Gems D., Harshman L.G., Oldham S., Stocker H., Hafen E., Leevers S.J., and Partridge L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292 (2001) 104-106
15. Dominici F.P., Hauck S., Argentino D.P., Bartke A., and Turyn D. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. J. Endocrinol. 173 (2002) 81-94
16. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
17. Efstathiou S.P., Tsioulos D.I., Tsiakou A.G., Gratsias Y.E., Pefanis A.V., and Mountokalakis T.D. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 36 (2005) 1915-1919
18. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat. Med. 10 (2004) 355-361
19. Evert J., Lawler E., Bogan H., and Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J. Gerontol. A: Biol. Sci. Med. Sci. 58 (2003) M232-M237
20. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116 (2004) 337-350
21. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
22. Gabriely I., Ma X.H., Yang X.M., Atzmon G., Rajala M.W., Berg A.H., Scherer P., Rossetti L., and Barzilai N. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 51 (2002) 2951-2958
23. Goodpaster B.H., Krishnaswami S., Harris T.B., Katsiaras A., Kritchevsky S.B., Simonsick E.M., Nevitt M., Holvoet P., and Newman A.B. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 165 (2005) 777-783
24. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., Cervera P., and Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421 (2003) 182-187
25. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1595-1599
26. Janssen J.A., and Lamberts S.W. IGF-I and longevity. Horm. Res. 62 Suppl. 3 (2004) 104-109
27. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm. IGF Res. 13 (2003) 113-170
28. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15-25
29. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 106 (2000) 473-481
30. Kanaya A.M., Wassel Fyr C., Vittinghoff E., Harris T.B., Park S.W., Goodpaster B.H., Tylavsky F., and Cummings S.R. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. Arch. Intern. Med. 166 (2006) 350-356
31. Kenyon C., Chang J., Gensch E., Rudner A., and Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 366 (1993) 461-464
32. Kloting N., and Blüher M. Extended longevity and insulin signaling in adipose tissue. 40 (2005) 878-883
33. Kobayashi J., Nishimura K., Matoba M., Maekawa N., and Mabuchi H. Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria. Circ. J. 71 (2007) 1734-1737
34. Kojima T., Kamei H., Aizu T., Arai Y., Takayama M., Nakazawa S., Ebihara Y., Inagaki H., Masui Y., Gondo Y., Sakaki Y., and Hirose N. Association analysis between longevity in the Japanese population and polymorphic variants of genes involved in insulin and insulin-like growth factor 1 signaling pathways. Exp. Gerontol. 39 (2004) 1595-1598
35. Lamberts S.W., Van Den Beld A.W., and Van Der Lely A.-J. The endocrinology of aging. Science 278 (1997) 419-424
36. Leow M.K.S., Addy C.L., and Mantzoros C.S. Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies. J. Clin. Endocrinol. Metab. 88 (2003) 1961-1976
37. Liu J.L., Coschigano K.T., Robertson K., Lipsett M., Guo Y., Kopchick J.J., Kumar U., and Liu Y.L. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E405-E413
38. Longo V.D., and Finch C.E. Evolutionary medicine: from dwarf model systems to healthy centenarians?. Science 299 (2003) 1342-1346
39. Louhija, J., 1994. Finnish Centenarians: A Clinical Epidemiological Study (Thesis/Dissertation). Helsinki University Press, Finland.
40. Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 3 (2006) 35-42
41. Morris J.Z., Tissenbaum H.A., and Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382 (1996) 536-539
42. Motta M., Bennati E., Ferlito L., Malaguarnera M., and Motta L. Successful aging in centenarians: myths and reality. Arch. Gerontol. Geriatr. 40 (2005) 241-251
43. Murakami S., Salmon A., and Miller R.A. Multiplex stress resistance in cells from long-lived dwarf mice. FASEB J. 17 (2003) 1565-1566
44. Niedernhofer L.J., Garinis G.A., Raams A., Lalai A.S., Robinson A.R., Appeldoorn E., Odijk H., Oostendorp R., Ahmad A., Van Leeuwen W., Theil A.F., Vermeulen W., Van Der Horst G.T.J., Meinecke P., Kleijer W.J., Vijg J., Jaspers N.G.J., and Hoeijmakers J.H.J. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444 (2006) 1038-1043
45. Otabe S., Yuan X., Fukutani T., Wada N., Hashinaga T., Nakayama H., Hirota N., Kojima M., and Yamada K. Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E210-E218
46. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., and Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
47. Paolisso G., Gambardella A., Ammendola S., D'Amore A., Balbi V., Varricchio M., and D'Onofrio F. Glucose tolerance and insulin action in healthy centenarians. Am. J. Physiol. Endocrinol. Metab. 270 (1996) E890-E894
48. Paolisso G., Gambardella A., Balbi V., Ammendola S., D'Amore A., and Varricchio M. Body composition, body fat distribution, and resting metabolic rate in healthy centenarians. Am. J. Clin. Nutr. 62 (1995) 746-750
49. Paolisso G., Ammendola S., Del Buono A., Gambardella A., Riondino M., Tagliamonte M.R., Rizzo M.R., Carella C., and Varricchio M. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J. Clin. Endocrinol. Metab. 82 (1997) 2204-2209
50. Reaven, G.M., Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
51. Salmon A.B., Murakami S., Bartke A., Kopchick J., Yasumura K., and Miller R.A. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E23-E29
52. Santaniemi M., Kesaniemi Y.A., and Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur. J. Endocrinol. 155 (2006) 745-750
53. Sethi J.K., and Vidal-Puig A.J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 48 (2007) 1253-1262
54. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R.S., Youngren J.F., Havel P.J., Pratley R.E., Bogardus C., and Tataranni P.A. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51 (2002) 1884-1888
55. Suh Y., Atzmon G., Cho M.O., Hwang D., Liu B., Leahy D.J., Barzilai N., and Cohen P. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 3438-3442
56. Takayama M., Hirose N., Arai Y., Gondo Y., Shimizu K., Ebihara Y., Yamamura K., Nakazawa S., Inagaki H., Masui Y., and Kitagawa K. Morbidity of Tokyo-area centenarians and its relationship to functional status. J. Gerontol. A: Biol. Sci. Med. Sci. 62 (2007) 774-782
57. Tatar M., Kopelman A., Epstein D., Tu M.P., Yin C.M., and Garofalo R.S. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292 (2001) 107-110
58. The Ministry of Health, Labour and Welfare. The Fifth National Survey of Cardiovascular Diseases. http://wwwdbtk.mhlw.go.jp/toukei/kouhyo/indexkk_18_1.html.
59. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 27 (2006) 762-778
60. Uno K., Katagiri H., Yamada T., Ishigaki Y., Ogihara T., Imai J., Hasegawa Y., Gao J., Kaneko K., Iwasaki H., Ishihara H., Sasano H., Inukai K., Mizuguchi H., Asano T., Shiota M., Nakazato M., and Oka Y. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312 (2006) 1656-1659
61. Villareal D.T., Miller III B.V., Banks M., Fontana L., Sinacore D.R., and Klein S. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am. J. Clin. Nutr. 84 (2006) 1317-1323
62. Wang Z., Al-Regaiey K.A., Masternak M.M., and Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J. Gerontol. A: Biol. Sci. Med. Sci. 61 (2006) 323-331
63. Wang Z., Masternak M.M., Al-Regaiey K.A., and Bartke A. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148 (2007) 2845-2853
64. Xydakis A.M., Case C.C., Jones P.H., Hoogeveen R.C., Liu M.Y., Smith E.O., Nelson K.W., and Ballantyne C.M. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J. Clin. Endocrinol. Metab. 89 (2004) 2697-2703